223 related articles for article (PubMed ID: 29092096)
1. Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service.
Capelle H; Tummino C; Greillier L; Gouitaa M; Birnbaum J; Ausias N; Barlesi F; Montana M
J Clin Pharm Ther; 2018 Jun; 43(3):320-326. PubMed ID: 29092096
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and predictive value of skin testing in platinum salt hypersensitivity.
Leguy-Seguin V; Jolimoy G; Coudert B; Pernot C; Dalac S; Vabres P; Collet E
J Allergy Clin Immunol; 2007 Mar; 119(3):726-30. PubMed ID: 17258305
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cutaneous reactions with pemetrexed: Comparison of patients who received three days of oral dexamethasone twice daily to patients who did not.
Clark SK; Anselmo LM
J Oncol Pharm Pract; 2019 Oct; 25(7):1645-1650. PubMed ID: 30319062
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin.
Enrique E; Malek T; Castelló JV; de Mateo JA
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):86. PubMed ID: 18254488
[No Abstract] [Full Text] [Related]
5. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
Pagani M; Bonadonna P; Senna GE; Antico A
Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of allergic reactions to platinum salts].
Touraine F; Sainte Laudy J; Boumediene A; Ndikumwenayo F; Decroisette C; Melloni B; Vergnenegre A; Bonnaud F
Rev Mal Respir; 2006 Nov; 23(5 Pt 1):458-62. PubMed ID: 17314746
[TBL] [Abstract][Full Text] [Related]
7. Low Cross-Reactivity Between Cisplatin and Other Platinum Salts.
Pasteur J; Favier L; Pernot C; Guerriaud M; Bernigaud C; Lepage C; Jouve JL; Isambert N; Collet E
J Allergy Clin Immunol Pract; 2019; 7(6):1894-1900. PubMed ID: 30776524
[TBL] [Abstract][Full Text] [Related]
8. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].
Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A
Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501
[TBL] [Abstract][Full Text] [Related]
9. Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds.
Pedraza-Nieto L; Beunza-Sola M; Rodríguez CA; Moreno E; Otero MJ
Int J Clin Pharm; 2021 Aug; 43(4):1123-1127. PubMed ID: 33937971
[TBL] [Abstract][Full Text] [Related]
10. [Platinum salts hypersensitivity].
Couraud S; Planus C; Rioufol C; Mornex F
Rev Pneumol Clin; 2008 Feb; 64(1):20-6. PubMed ID: 18603175
[TBL] [Abstract][Full Text] [Related]
11. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
Spoerl D; Nigolian H; Czarnetzki C; Harr T
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.
Caiado J; Picard M
Curr Allergy Asthma Rep; 2014 Aug; 14(8):451. PubMed ID: 24951237
[TBL] [Abstract][Full Text] [Related]
13. Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
Otani IM; Wong J; Banerji A
Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633
[TBL] [Abstract][Full Text] [Related]
14. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
[TBL] [Abstract][Full Text] [Related]
15. Safety of Same-Day Vitamin B12 Supplementation in Patients Receiving Pemetrexed for the Treatment of Non-Small-Cell Lung Cancer or Pleural Mesothelioma: A Retrospective Analysis.
Schlei Z; Tan W; Faber MG; Chen H; Meagher A; Dy GK
Clin Lung Cancer; 2018 Nov; 19(6):467-475. PubMed ID: 30369425
[TBL] [Abstract][Full Text] [Related]
16. Skin tests in the diagnosis of drug hypersensitivity reactions.
Brockow K; Romano A
Curr Pharm Des; 2008; 14(27):2778-91. PubMed ID: 18991697
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial.
Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741
[TBL] [Abstract][Full Text] [Related]
18. Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.
Giavina-Bianchi P; Galvão VR; Picard M; Caiado J; Castells MC
J Allergy Clin Immunol Pract; 2017; 5(3):728-736. PubMed ID: 28034549
[TBL] [Abstract][Full Text] [Related]
19. Diagnosing hypersensitivity reactions to cephalosporins in children.
Romano A; Gaeta F; Valluzzi RL; Alonzi C; Viola M; Bousquet PJ
Pediatrics; 2008 Sep; 122(3):521-7. PubMed ID: 18762521
[TBL] [Abstract][Full Text] [Related]
20. Effect of renal function on pemetrexed-induced haematotoxicity.
Ando Y; Hayashi T; Ujita M; Murai S; Ohta H; Ito K; Yamaguchi T; Funatsu M; Ikeda Y; Imaizumi K; Kawada K; Yasuda K; Yamada S
Cancer Chemother Pharmacol; 2016 Jul; 78(1):183-9. PubMed ID: 27286996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
